Market analysts predict the global minimally invasive spine surgery market will continue to grow in the coming years.
Here are five of the top companies in the market according to a Research and Markets report and how they compare based on their 2018 second quarter financial reports.
1. Zimmer Biomet: At the end of the quarter, the company recorded $2 billion in sales, a 3 percent increase year-over-year. The company's spine business also generated $198 million in sales, a 2.5 percent increase year-over-year.
2. DePuy Synthes: The company's worldwide sales hit $2.2 billion, a 1.4 percent decrease over the same period last year. DePuy Synthes spine and other sales dropped 7.7 percent, led by a 9.2 percent decrease in international sales to $347 million. U.S. spine and other sales also dropped 6.6 percent to $498 million.
3. Stryker: The company reported net sales of $3.3 billion in the second quarter, a 10.3 percent increase year-over-year. Stryker's neurotechnology and spine segment reported $600M in sales, a 19.4 percent increase year-over-year.
4. Medtronic: The company reported a 0.1 percent decrease in worldwide revenue to $7.3 billion. Spine revenue hit $652 million for the quarter, a 0.5 percent increase over the same period last year.
5. NuVasive: The company experienced an 8.5 percent increase in year-over-year revenues, topping $281.6 million. NuVasive's second quarter income sits at $11.5 million,or $0.22 per share.